Skip to main content

Table 2 Analysis of differential expression of whole blood mRNA in ATB and LTBI patients by dcRT-MLPA method

From: Gene expression pattern analysis using dual-color RT-MLPA and integrative genome-wide association studies of eQTL for tuberculosis suscepitibility

mRNA

ATB

LTBI

P value

mRNA

ATB

LTBI

P value

mRNA

ATB

LTBI

P value

Il4

5.52

6.73

 < 0.0001

Sec14l

2.859

3.2

0.0592

Timp2

8.155

8.266

0.5858

Il7r

9.15

8.147

 < 0.0001

ltf

7.125

6.53

0.0761

Casp8

12.26

12.36

0.6134

Il8

9.254

9.844

 < 0.0001

Mmp9

6.34

6.155

0.0969

Tnfrsf1a

12.04

12.01

0.7111

Tnfrsf1b

9.93

10.42

0.0001

Ccr7

13.02

12.93

0.1686

Ifng

9.85

9.82

0.717

Pgm5

9.11

7.982

0.0016

Bcl2

3.825

4.19

0.2555

Tgfb1

12.68

12.68

0.7831

Ccl19

9.28

8.435

0.0034

Cd4

5.815

5.71

0.3819

Cd8a

8.735

8.66

0.8726

Il2ra

7.445

7.784

0.0143

Il6

4.472

4.1

0.4205

Foxp3

11.04

10.96

0.8905

Marco

5.98

5.44

0.0174

Tnfrsf10c

10.38

10.48

0.4313

Blr1

6.32

6.336

0.9785

Fpr1

4.47

4.178

0.0206

Fcgr1a

5.03

5.041

0.4422

Cxcl10

10.41

10.37

0.9953

  1. The 9 mRNAs in the first column showed significant differences in expression levels between the ATB and LTBI groups. Among them, il7r, pgm5, ccl19, marco, and fpr1 were up-regulated in ATB patients. Il4, il8, tnfrsf1b, and il2ra were up-regulated in LTBI patients
  2. ATB active tuberculosis, LTBI latent tuberculosis infection